Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea
Table 2
Comparison of laboratory results between OSA patients and controls.
Variables
Controls ()
OSA ()
value
Platelet (G/L)
216.0 (173.5-262.8)
215.5 (190.0-249.5)
0.885
Leukocyte (G/L)
5.6 (4.8-7.5)
6.2 (5.5-7.1)
0.135
FBG (mmol/L)
5.1 (4.8-5.4)
5.5 (5.1-6.1)
0.004
Uric acid (μmol/L)
<0.001
Urea nitrogen (mmol/L)
4.5 (4.1-5.9)
5.1 (4.3-6.4)
0.054
Creatinine (μmol/L)
<0.001
Creatine kinase (U/L)
0.402
Total cholesterol (mmol/L)
4.2 (3.6-5.0)
4.7 (3.7-5.4)
<0.001
Triglyceride (mmol/L)
1.5 (1.0-2.0)
1.5 (1.1-2.0)
0.144
HDL (mmol/L)
1.3 (1.2-1.4)
1.1 (1.1-1.2)
0.042
LDL (mmol/L)
2.6 (1.2-4.2)
2.1 (1.6-2.9)
0.275
hsCRP (mg/L)
0.9 (0.3-3.4)
1.4 (0.6-3.5)
0.094
GGT (U/L)
26.0 (16.8-36.8)
33.0 (22.0-48.3)
0.001
ALT (U/L)
21.5 (13.0-30.5)
26.0 (17.0-36.0)
0.024
AST (U/L)
20.0 (18.0-24.3)
21.0 (18.0-28.0)
0.162
ADAMTS13 (μg/mL)
0.8 (0.5-1.7)
2.7 (2.2-3.2)
<0.001
Data are presented as or (%), , or median (interquartile range, IQR), unless otherwise stated. FBG: fasting blood glucose; HDL: high-density lipoprotein; LDL: low-density lipoprotein; FBG: fasting blood glucose; hsCRP: high-sensitivity C-reactive protein; GGT: γ-glutamyl transferase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ADAMTS13: a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13.
